It’s no longer science fiction. The use of drones promises to provide those with chronic medical conditions with faster and easier access to the therapies they need.
Anthem Inc. intends to change its name to Elevance Health Inc., as the company looks to shift its focus beyond the health insurance business.
CVS Health Corp.’s pharmacy benefit management (PBM) unit is launching a new program under which employers and insurers will be able to offer diabetes drugs, including insulin, at no out-of-pocket costs to their members.
With a Pharma Market Free of Rebates, We Can Sell on Value Again
Business, Cancer, Cardiovascular Disease, Consumers, CVS Health, Department of Health and Human Services (HHS), Drug Pricing, Drug Rebates, Drug Wholesalers, Drugs, Health Insurers, Health Outcomes, HIV/AIDS, Issue Archives, June 2019, Manufacturers, Pharma, Pharmacy Benefit Management (PBM) Business, Retail Pharmacies, Supply ChainThe pharmaceutical industry’s greatest value lies in the quality of life that its drugs provide – plus the innovative programs that help support adherence and education.
Sen. Sanders, Rep. Cummings to introduce bill to lower U.S. drug prices
Britain, Canada, Consumers, Democrats, Department of Health and Human Services (HHS), Donald Trump, France, Germany, House of Representatives, Japan, Medicare Part D, Pharmacy Benefit Management (PBM) Business, Pricing, Republicans, Senators, TherapeuticsU.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation aimed at lowering the cost of prescription drugs for U.S. consumers.
Pharmacy chain CVS Health Corp. won U.S. antitrust approval for the $69 billion acquisition of health insurer Aetna Inc., the Justice Department said.
Amgen Inc.’s push to get patients on its new $575 a month migraine drug before competition emerges in September 2018 is facing barriers from insurers.
With two major prescription drug supply deals announced within a four-month period, the landscape of pharmacy benefits management is changing dramatically.
Special Feature – Value of Medicines: The value equation
Business, CAR-T Therapy, Centers for Medicare & Medicaid Services, Drug Pricing, DTC, February 2018, Gene Therapy, Immunotherapies, Innovation, Issue Archives, Medicines, Payers, Pharmacy Benefit Management (PBM) Business, Therapeutics, Value of MedicinesAs more innovative – yet even more expensive – therapies enter the U.S. market, brand marketers will have to find equally new and innovative ways to prove the value of their medicines to payers and patients, especially as insurance plans continue to put more of the cost burden on patients.
Goldman Sachs published a 30-page report on how Amazon could break into the prescription drug market. Written by five analysts, the report points out that although Amazon has not explicitly stated it is interested in entering the prescription drug market, it has developed the secretive 1492 group, which is reportedly working on medical devices, and hired Missy Krasner, former vice president and managing director of Box’s healthcare and life sciences group to head up its pharmacy group. Box markets cloud management products and services.